Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Mallinckrodt
Cipla
Dow
Teva
Johnson and Johnson
AstraZeneca
US Department of Justice
Novartis

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,906,962

« Back to Dashboard

Which drugs does patent 8,906,962 protect, and when does it expire?

Patent 8,906,962 protects LATISSE and is included in one NDA.

This patent has sixteen patent family members in nine countries.
Summary for Patent: 8,906,962
Title:Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
Inventor(s): deLong; Mitchell A. (Chapel Hill, NC), McIver; John M. (Cincinnati, OH), Youngquist; Robert S. (Mason, OH)
Assignee: Duke University (Durham, NC)
Application Number:14/034,372
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 8,906,962

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Allergan LATISSE bimatoprost SOLUTION/DROPS;TOPICAL 022369-001 Dec 24, 2008 AT RX Yes Yes ➤ Sign Up ➤ Sign Up METHOD OF INCREASING HAIR GROWTH ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,906,962

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,388,029 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins ➤ Sign Up
8,541,466 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins ➤ Sign Up
9,579,270 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,906,962

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 309775 ➤ Sign Up
Australia 5303901 ➤ Sign Up
Canada 2401731 ➤ Sign Up
China 100384425 ➤ Sign Up
China 101229171 ➤ Sign Up
China 101897700 ➤ Sign Up
China 1522135 ➤ Sign Up
Germany 60115000 ➤ Sign Up
European Patent Office 1267807 ➤ Sign Up
Spain 2252215 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Dow
Medtronic
UBS
Accenture
Queensland Health
Healthtrust
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot